Tech & Pharma

Senhwa Biosciences Raises US$17m For Cancer Clinical Trials

Senhwa Biosciences Raises US$17m For Cancer Clinical Trials

Senhwa Biosciences has raised an additional US$17 million in Series B financing to drive its anticancer agents through critical clinical trials.

MTIA To Commercialize Echo Therapeutic’s Glucose Sensor

MTIA To Commercialize Echo Therapeutic’s Glucose Sensor

Echo Therapeutics, Inc. has granted Medical Technologies Innovation Asia, Ltd. rights to commercialize Echo’s Symphony CGM System in China.

Omron Healthcare To Distribute Diabetes Detection Test In China

Omron Healthcare To Distribute Diabetes Detection Test In China

Omron Healthcare will exclusively distribute NeuroMetrix’s point-of-care test for early detection of diabetic peripheral neuropathy in China.

ScinoPharm To Open Manufacturing Plant In Changshu, China

ScinoPharm To Open Manufacturing Plant In Changshu, China

ScinoPharm has completed construction of its Changshu plant on a 16-acre site in China.

A*STAR, KHIDI Sign MOU For Scientific Collaboration

A*STAR, KHIDI Sign MOU For Scientific Collaboration

A*STAR and KHIDI have signed a MOU to symbolize their growing bilateral cooperation in the field of biomedical sciences.

Strand Life Sciences Opens Genomics Center In San Francisco

Strand Life Sciences Opens Genomics Center In San Francisco

Strand Life Sciences is collaborating with El Camino Hospital to open a Strand Center for Genomics and Personalized Medicine in San Francisco, US.

IXICO, UMP To Improve Dementia Diagnostics In China

IXICO, UMP To Improve Dementia Diagnostics In China

IXICO plc and Beijing Union Medical have signed an MoU to jointly work on improving the diagnosis and treatment of dementia in China.

Oral Proteasome Inhibitor Could Improve Multiple Myeloma Treatment

Oral Proteasome Inhibitor Could Improve Multiple Myeloma Treatment

Takeda has announced clinical study results combining oral investigational MLN9708 with lenalidomide and dexamethasone, in patients with newly diagnosed multiple myeloma.

Teva, Takeda To Commercialize Multiple Sclerosis Drug

Teva, Takeda To Commercialize Multiple Sclerosis Drug

Teva and Takeda will jointly commercialize Teva’s glatiramer acetate formulation for the treatment of multiple sclerosis in Japan.

Swiss Pharma Helsinn Group Opens Chinese Unit

Swiss Pharma Helsinn Group Opens Chinese Unit

Helsinn Group, a Swiss pharmaceutical company that focuses on oncologic products, has opened a representative office in Beijing, China.